Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 68382-595

6 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 68382-595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 01)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 01)
Chemical structure of diltiazem hydrochloride, showing the molecular arrangement including benzene rings, methoxy group (OCH3), and hydrochloride (HCl) moiety.*
FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 02)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 02)
Label for Diltiazem Hydrochloride Extended-Release Capsules, USP, 120 mg strength. Oral capsules in a 90-count package. Label includes a capsule image marked '595' with two colors (turquoise and white). Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Storage and safety instructions are provided.*
FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 03)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 03)
Label for diltiazem hydrochloride extended-release capsules, USP 180 mg, oral dosage form. The label indicates a 90-capsule package with once-a-day dosage instructions. It includes storage directions and warnings, and shows the labeler as Zydus Pharmaceuticals (USA) Inc. The label also displays a capsule image and mentions manufacturing by Cadila Healthcare Ltd, India.*
FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 04)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 04)
Label for Diltiazem Hydrochloride Extended-Release Capsules, USP 240 mg by Zydus Pharmaceuticals (USA) Inc. The label includes dosage form as extended-release capsules, a count of 90 capsules, and emphasizes once-a-day dosage. It shows a capsule image marked with '597' and contains storage and handling instructions. It has a barcode and NDC 68382-597-16.*
FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 05)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 05)
Label for diltiazem hydrochloride extended-release oral capsules, USP 300 mg, supplied by Zydus Pharmaceuticals (USA) Inc. The package contains 90 capsules, indicated for once-a-day dosage. The label includes handling instructions, storage conditions, and manufacturer details, with a visual of a bicolor capsule and barcode.*
FDA Label Image

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 06)

Figure (8ae77338 81c1 4b29 992d 318d0549cf39 06)
Label for diltiazem hydrochloride extended-release capsules, USP, 360 mg by Zydus Pharmaceuticals (USA) Inc. The package contains 90 capsules with a once-a-day dosage. It includes storage instructions and warnings, noting the manufacturer as Cadila Healthcare Ltd., India, and distributor Zydus Pharmaceuticals (USA).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.